Epam (EPAM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Epam reported revenue of $1.35 billion for the quarter ended June 2025, reflecting an 18% increase year-over-year and a surprise of +1.53% over the Zacks Consensus Estimate of $1.33 billion [1] - The earnings per share (EPS) was $2.45, unchanged from the same quarter last year, but fell short of the consensus estimate of $2.61, resulting in an EPS surprise of -6.13% [1] Revenue Performance by Geography - Americas revenue reached $801.43 million, exceeding the average estimate of $799.89 million, with a year-over-year increase of +16% [4] - APAC revenue was $27.2 million, slightly above the average estimate of $27.19 million, marking a +13% year-over-year change [4] - EMEA revenue totaled $524.81 million, surpassing the average estimate of $498.6 million, with a significant year-over-year increase of +21.7% [4] Revenue Performance by Industry Verticals - Financial Services generated $328.31 million, exceeding the estimated $312.51 million, representing a robust +34.4% year-over-year growth [4] - Software & Hi-Tech revenue was $204.67 million, above the estimated $189.86 million, reflecting a +21.2% increase year-over-year [4] - Life Sciences & Healthcare revenue was $156.51 million, slightly below the estimated $162.54 million, with a +11.7% year-over-year change [4] - Emerging Verticals achieved $225.51 million, surpassing the estimated $215.24 million, indicating a +28.7% year-over-year growth [4] - Consumer Goods, Retail & Travel revenue was $268.05 million, slightly below the estimated $269.77 million, with a +6.2% year-over-year increase [4] Revenue Performance by Contract Type - Time-and-material contracts generated $1.09 billion, below the estimated $1.12 billion, with a +15.2% year-over-year increase [4] - Fixed-price contracts reached $258 million, exceeding the estimated $205.76 million, representing a +31.9% year-over-year growth [4] - Licensing and other revenues were $8.05 million, below the estimated $10.78 million, with a +9.9% year-over-year change [4] Stock Performance - Epam's shares have returned -11.3% over the past month, contrasting with the Zacks S&P 500 composite's +1.9% change, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3]